Kristine, are you not in the U.S.? Last I heard, Fareston was approved for use by premenopausal women in Europe, but in this country was still undergoing trials for anything other than metastatic breast cancer in postmenopausal women; it hadn't yet been FDA approved. So if you're in America, I'd ask your doctor pretty closely about when the trials were completed, and the results, and when the FDA approved it. It's true, Fareston doesn't come with the risk of endometrial cancer that tamoxifen does. However, tamoxifen has been in use for 30+ years, and is a proven winner. I don't know about the liver disease connection. Bottom line: discuss this with your doctor further. Good luck - PJH